Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2023-05-09 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Just Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
Regulatory Filings Classification · 1% confidence The document is a news release dated May 9, 2023, announcing a 'tech partnership for biosimilars development and commercial manufacturing' between Evotec's subsidiary and Sandoz. It details financial terms (upfront payments, success milestones) and future collaboration plans. This type of announcement, which details a significant business development, partnership, or strategic agreement, does not fit the specific categories like 10-K (Annual Report), ER (Earnings Release), or CT (Call Transcript). It is a corporate announcement regarding business strategy and potential future revenue streams, but it is not explicitly a financing event (CAP) or a merger/takeover (TAR). Since it is a general corporate news item distributed via EQS News, and it doesn't fit the highly specific categories, the most appropriate classification is the general regulatory/corporate announcement fallback, RNS (Regulatory Filings), as it is a material event disclosure.
2023-05-09 English
Just Evotec Biologics enters strategic biosimilars partnership with Sandoz
Regulatory Filings Classification · 1% confidence The document is an 'Ad-hoc' release dated May 9, 2023, disclosing 'Inside Information' according to MAR Regulation (EU) No 596/2014. It announces a strategic partnership between Evotec's subsidiary and Sandoz regarding biosimilars development and manufacturing, including financial terms (upfront payments, future payments up to US$ 640m). This type of announcement, detailing a significant business development, partnership, or material contract that is not a standard periodic financial report (like 10-K or IR), typically falls under general regulatory announcements or news releases. Since it is a specific, material business event disclosure mandated by EU regulation (MAR), and it doesn't fit the definitions for M&A (TAR), Financing (CAP), or Earnings (ER), the most appropriate general category for significant, non-standard regulatory news is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous regulatory announcements not covered by other specific codes.
2023-05-09 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a legal entity (T. Rowe Price International Funds, Inc.) in Evotec SE, referencing specific German securities law articles (WpHG). This directly corresponds to the definition of reporting changes in significant share ownership thresholds. The most appropriate classification among the provided options is 'Major Shareholding Notification' (MRQ). Although it mentions 'Voting Rights Announcement' in the header, MRQ specifically covers the notification of crossing ownership thresholds, which is the core content here.
2023-05-05 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 1% confidence The document is titled "Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is a preliminary announcement regarding the disclosure date (May 11, 2023) and location of the 'Quarterly financial report within the 1st half-year (Q1)'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies the document as a Report Publication Announcement (RPA), not the report itself (which would be an IR). The document length (1779 chars) supports this being an announcement rather than the full report.
2023-05-02 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 1% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that the Annual financial report and Annual financial report of the group will be disclosed on a future date (May 11, 2023) and provides links to where they will be available. Since the document itself is an announcement about the future release of reports, rather than the reports themselves, it fits the definition of a Report Publication Announcement (RPA). The document length (2327 chars) is short, supporting the 'MENU VS MEAL' rule application.
2023-05-02 English
Declaration of Corporate Management 2022
Governance Information Classification · 1% confidence The document is explicitly titled "Declaration on corporate governance for the financial year 2022" and contains detailed sections on the "Declaration of compliance with the German Corporate Governance Code pursuant to Section 161 German Stock Corporation Act (AktG) for the 2022 financial year," as well as descriptions of the working practices and composition of the Management Board and Supervisory Board. This content directly relates to the company's internal rules, board structure, and governance practices, which aligns perfectly with the definition of Governance Information (CGR). It is not an Annual Report (10-K), an Interim Report (IR), or a general Earnings Release (ER).
2023-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.